Skip to main content
. 2020 Jan 22;23(1):47–58. doi: 10.4048/jbc.2020.23.e11

Figure 2. pCR rates in patients with different Tau protein levels among different molecular subtypes. (A) All patients were divided into 2 molecular subtypes. (B) All patients were divided into 3 molecular subtypes. p-values are from the χ2 test for trend. pCR is defined as ypT0N0 or ypTisN0.

Figure 2

pCR = pathological complete response; HER2 = human epidermal growth factor receptor 2; TNBC = triple-negative breast cancer.